These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32175662)

  • 1. Intracoronary application of nicorandil regulates the inflammatory response induced by percutaneous coronary intervention.
    Hu K; Wang X; Hu H; Xu Z; Zhang J; An G; Su G
    J Cell Mol Med; 2020 Apr; 24(8):4863-4870. PubMed ID: 32175662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nicorandil on systemic inflammation and oxidative stress induced by percutaneous coronary intervention in patients with coronary heart disease.
    Zong Y; Li J; Xu X; Xu X
    J Int Med Res; 2021 Dec; 49(12):3000605211058873. PubMed ID: 34871513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
    Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
    Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.
    Lim SY; Bae EH; Jeong MH; Kang DG; Lee YS; Kim KH; Lee SH; Yoon KH; Hong SN; Park HW; Hong YJ; Kim JH; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
    Circ J; 2004 Oct; 68(10):928-32. PubMed ID: 15459466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients: Protocol of a double-blinded, randomized, placebo-controlled trial.
    An S; Huang H; Wang H; Jiang Y
    Medicine (Baltimore); 2021 Apr; 100(15):e25500. PubMed ID: 33847663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical potential of oral nicorandil to improve myocardial fatty acid metabolism after percutaneous coronary intervention in hemodialysis patients.
    Nishimura M; Okamoto Y; Tokoro T; Sato N; Nishida M; Hashimoto T; Kobayashi H; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T
    Nephron Clin Pract; 2014; 126(1):24-32. PubMed ID: 24434794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
    Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
    EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
    Feng C; Liu Y; Wang L; Niu D; Han B
    Heart Lung Circ; 2019 Jun; 28(6):858-865. PubMed ID: 29891250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
    Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
    Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
    Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention.
    Sato S; Takahashi M; Mikamo H; Kawazoe M; Iizuka T; Shimizu K; Noro M; Shirai K
    Heart Vessels; 2020 Dec; 35(12):1664-1671. PubMed ID: 32572567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of myocardial viability within the risk area by intravenous nicorandil before primary coronary intervention in patients with acute myocardial infarction.
    Umemura S; Nakamura S; Sugiura T; Tsuka Y; Shimojo M; Baden M; Iwasaka T
    Nucl Med Commun; 2008 Nov; 29(11):956-62. PubMed ID: 18836373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intracoronary nicorandil before stent deployment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xu X; Liu X; Yu L; Ma J; Yu S; Ni M
    Exp Ther Med; 2020 Jan; 19(1):137-146. PubMed ID: 31853283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of intracoronary nicorandil on microvascular dysfunction after primary percutaneous coronary intervention: demonstration of its superiority to nitroglycerin in a cross-over study.
    Ito N; Nanto S; Doi Y; Kurozumi Y; Natsukawa T; Shibata H; Morita M; Kawata A; Tsuruoka A; Sawano H; Okada K; Sakata Y; Kai T; Hayashi T
    Cardiovasc Drugs Ther; 2013 Aug; 27(4):279-87. PubMed ID: 23722418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial.
    Zhang W; Dai J; Zheng X; Xu K; Yang X; Shen L; Wang X; Hao Z; Qiu X; Jiang L; Shi H; Shen L; He B
    Medicine (Baltimore); 2021 Apr; 100(15):e25551. PubMed ID: 33847683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
    Pang Z; Zhao W; Yao Z
    Med Sci Monit; 2017 Jun; 23():2924-2930. PubMed ID: 28617765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High index of microcirculatory resistance level after successful primary percutaneous coronary intervention can be improved by intracoronary administration of nicorandil.
    Ito N; Nanto S; Doi Y; Sawano H; Masuda D; Yamashita S; Okada K; Kaibe S; Hayashi Y; Kai T; Hayashi T
    Circ J; 2010 May; 74(5):909-15. PubMed ID: 20234097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of nicorandil on infarct myocardium in comparison with nitrate: assessed by cardiac magnetic resonance imaging.
    Yamada K; Isobe S; Ishii H; Yokouchi K; Iwata H; Sawada K; Murohara T
    Heart Vessels; 2016 Sep; 31(9):1430-7. PubMed ID: 26531829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.